These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 3524934

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH.
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study Investigators.
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [Abstract] [Full Text] [Related]

  • 6. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [Abstract] [Full Text] [Related]

  • 7. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS.
    Med J Aust; 1985 Jan 07; 142(1):41-7. PubMed ID: 3880861
    [Abstract] [Full Text] [Related]

  • 8. Prophylaxis and acute therapy of arterial embolism with special reference to cerebral embolism.
    Tettenborn B, Krämer G, Erbel R.
    Herz; 1991 Dec 07; 16(6):444-55. PubMed ID: 1765348
    [Abstract] [Full Text] [Related]

  • 9. [Thrombolytic therapy in arterial disorders other than myocardial infarction].
    Verstraete M.
    Arch Mal Coeur Vaiss; 1996 Jan 07; 89(1):77-82. PubMed ID: 8678742
    [Abstract] [Full Text] [Related]

  • 10. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S, Lessem J, Jha P, Lonn E.
    J Hypertens Suppl; 1993 Jun 07; 11(4):S61-73. PubMed ID: 8104243
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The use of antithrombotic drugs in older people.
    Tufano A, Cerbone AM, Di Minno G.
    Minerva Med; 2002 Feb 07; 93(1):13-26. PubMed ID: 11850611
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiplatelet drugs in arterial thrombosis: a review.
    Tsu EC.
    Am J Hosp Pharm; 1978 Dec 07; 35(12):1507-15. PubMed ID: 362914
    [Abstract] [Full Text] [Related]

  • 18. Effects of thrombolytic agents on coronary recanalization and patency, cardiac enzyme release, left ventricular function, and mortality in patients with acute myocardial infarction.
    Verstraete M.
    J Cardiovasc Pharmacol; 1989 Dec 07; 14 Suppl 9():S38-48. PubMed ID: 2483231
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.